A detailed history of Rakuten Securities, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Rakuten Securities, Inc. holds 1 shares of NBIX stock, worth $125. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 2 50.0%
Holding current value
$125
Previous $275,000 58.18%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$114.58 - $153.15 $114 - $153
-1 Reduced 50.0%
1 $115,000
Q2 2024

Jul 31, 2024

SELL
$130.86 - $143.19 $3,009 - $3,293
-23 Reduced 92.0%
2 $275,000
Q1 2024

May 01, 2024

SELL
$130.4 - $143.74 $391 - $431
-3 Reduced 10.71%
25 $3.45 Million
Q4 2023

Jan 30, 2024

BUY
$106.07 - $132.76 $2,969 - $3,717
28 New
28 $3.69 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Rakuten Securities, Inc. Portfolio

Follow Rakuten Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rakuten Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rakuten Securities, Inc. with notifications on news.